Alimentary Pharmacology and Therapeutics
- Print ISSN
- Electronic ISSN
- Impact factor
- Usage rank
- Article count
- Free count
- Free percentage
- PDFs via platforms
- Ebscoatoz, CSA, Ovid from 2000, Ebsconet, Wiley from 1987, Ebsco, Gale, and Proquest
Letter: effects of oxycodone and tapentadol dosage on gastrointestinal function - author's reply.
Letter: anti-TNFs and psoriasis - friends or foes? Authors' reply.
Microscopic colitis and disease associations: authors' reply.
Night-time intra-oesophageal bile and acid exposure in GERD patients failing PPI therapy: authors' reply.
Dyspepsia and irritable bowel syndrome: mutually exclusive conditions? authors' reply.
Letter from the editors.
More statistical analysis is needed for the meta-analysis of genetic association studies: authors' reply.
Enhancement of cytoprotective ability and cell restoration in 70-kDa heat shock protein gene-transfected rat gastric mucosal cells.
We successfully cloned HSP70 highly-expressing gastric mucosal cells, which expressed a level of HSP70 equal to 350% of that of RGM-1 cells. Over-expression of HSP70 clearly enhanced cytoprotective ability against H(2)O(2) or ethanol-induced cell damage. Wound restoration was enhanced in 7018-RGM-1...
Phase I study of paclitaxel plus irinotecan combination therapy for patients with refractory and advanced gastric cancer.
Background No adequate second-line chemotherapy regimen for advanced gastric cancer is available. Aims To determine the safety and optimal dose of paclitaxel/irinotecan as a second-line chemotherapy for patients with advanced and recurrent gastric cancer. Patients and methods Sixteen patients with r...
Infliximab regulates lamina propria T lymphocytes in patients with Crohn's disease.
We investigated changes in the serum level of cytokines after treatment in these patients, and the effect of infliximab in inducing the apoptosis of T lymphocytes. Methods Thirteen patients with Crohn's disease were treated with infliximab at a dosage of 5-mg/kg body weight. Clinical response was ev...